Meta-analysis results for all treatments

Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method

Treament Trials      
clinical deteriorationclinical improvementdeathsviral clearance
A EFFACER Janssen Ad.26.COV2.S vaccine (JNJ-78436725)0----
BBV152 (Bharat Biotech, India)0----
BCG vaccination0----
DNA vaccine0----
heterologous prime-boost0----
Inactivated virus vaccine0----
Non replicating viral vector0----
protein subunit vaccine0----
RNA vaccine0----
Sanofi/GSK recombinant protein vaccine0----
sequential Immunization0----
Shifa-Pharmed inactivated vaccine0----
vaccine 3rd dose0----
Vero cell0----
virus-like particles vaccine0----
Zy-Cov-D (Zydus Cadila)0----